Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Nordrest | NREST | Jan 10, 2025 | 112.20 | +0.90 |
Norion Bank AB | NORION | Jan 10, 2025 | 37.20 | -2.75 |
Northbaze Group | NBZ | Jan 10, 2025 | 0.21 | +24.85 |
Northern CapSek Ventures | CAPS | Jan 10, 2025 | 0.17 | 0.00 |
Northern CapSek Ventures PREF | CAPSPREF | Jan 10, 2025 | 0.69 | 0.00 |
Northgold | NG | Jan 10, 2025 | 0.60 | +3.42 |
Norva24 | NORVA | Jan 10, 2025 | 26.00 | -0.57 |
Nosa Plugs | NOSA | Jan 10, 2025 | 0.95 | 0.00 |
Nosium | NOSIUMB | Jan 10, 2025 | 6.76 | -0.59 |
Note | NOTE | Jan 10, 2025 | 146.30 | -2.47 |
Novotek B | NTEKB | Jan 10, 2025 | 74.60 | -0.80 |
Novus Group | NOVU | Jan 10, 2025 | 2.76 | -19.77 |
Nowonomics | NOWO | Jan 10, 2025 | 4.04 | +12.85 |
NP3 Fastigheter | NP3 | Jan 10, 2025 | 225.50 | -1.74 |
NP3 Fastigheter Pref | NP3PREF | Jan 10, 2025 | 30.00 | +0.17 |
NYAB | NYAB | Jan 10, 2025 | 4.78 | -2.75 |
Nyfosa | NYF | Jan 10, 2025 | 99.40 | -0.40 |
Obducat B | OBDUB | Jan 10, 2025 | 1.39 | +2.96 |
Observit | OBSE | Jan 10, 2025 | 0.45 | -2.68 |
ODI Pharma | ODI | Jan 10, 2025 | 3.78 | -3.08 |
Odinwell | ODIN | Jan 10, 2025 | 2.46 | +6.03 |
OEM International B | OEMB | Jan 10, 2025 | 110.60 | -0.18 |
Ogunsen B | OGUNB | Jan 10, 2025 | 32.45 | -1.52 |
OMX GES OMXS30 Ethical Price Index | OMXS30ETHIC | Jan 10, 2025 | 301.15 | 0.00 |
OMX NORDIC 40 | OMXN40 | Jan 10, 2025 | 2 523.26 | -0.52 |
OMX Oslo 20 GI | OMXO20GI | Jan 10, 2025 | 1 346.95 | +0.73 |
OMX Oslo 20 PI | OMXO20PI | Jan 10, 2025 | 742.36 | +0.73 |
OMX Stockholm 30 | OMXS30 | Jan 10, 2025 | 2 523.73 | -1.01 |
OMX Stockholm 30 GI | OMXS30GI | Jan 10, 2025 | 495.45 | -1.01 |
OMX Stockholm 60 Cap PI | OMXS60CAP | Jan 10, 2025 | 309.86 | -1.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.